** Shares of British consumer healthcare group Haleon HLN.L fall 1.6% to 345.1 pence
** Sensodyne maker among top losers on FTSE .FTSE, which is down 0.23%
** Q1 organic revenue growth of 2.2% slightly misses analyst expectations of 2.3%, according to co-compiled consensus
** HLN reiterates expectations for 3-5% organic revenue growth and high-single digit adjusted operating profit growth in 2026
** "We would expect a muted reaction to a slow start to the year with still low visibility ahead," J.P.Morgan analysts say
** As of last close, stock down 6.4% YTD, while .FTSE rose over 4%
(Reporting by DhanushVignesh Babu in Bengaluru)
((DhanushVignesh.Babu@thomsonreuters.com))